Mahender Gaba, MD
Cardiovascular Disease · Bullhead City, AZNPI 1104896174
Payments from drug & device makers
Across 217 payments — averaging $61.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abiomed$3K
- Boston Scientific$961
- W. L. Gore & Associates, Inc.$904
- Novartis$624
- Boehringer Ingelheim$549
- plus $3K from 24 others
What the payments were for
- Travel & lodging$7,19254%
- Food & beverage$6,05446%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 41 | $4,766 |
| Abiomed | 12 | $2,825 |
| Boston Scientific | 6 | $961 |
| W. L. Gore & Associates, Inc. | 5 | $904 |
| Novartis | 35 | $624 |
| Boehringer Ingelheim | 17 | $549 |
| Johnson & Johnson | 10 | $304 |
| Abbott | 3 | $293 |
| Shockwave Medical, Inc | 7 | $239 |
| Amgen | 13 | $223 |
| Pfizer | 9 | $214 |
| Novo Nordisk | 9 | $196 |
| Bayer | 10 | $162 |
| Baxter Healthcare | 3 | $137 |
| E.r. Squibb & Sons, L.L.C. | 7 | $135 |
| Merck | 6 | $119 |
| Philips North America LLC | 3 | $87 |
| Actelion Pharmaceuticals US, Inc. | 3 | $74 |
| Bard Peripheral Vascular, Inc. | 1 | $70 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $60 |
| AstraZeneca | 3 | $52 |
| Lexicon Pharmaceuticals, Inc. | 2 | $45 |
| Biosense Webster, Inc. | 1 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Heartflow, Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Edwards Lifesciences | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$2,417
- Micra$1,333
- TurboHawk$1,083
- GORE CARDIOFORM Septal Occluder$847
- CROSSBOSS$652
- NAVITOR$195
- AURORA EV-ICD MRI SURESCAN$175
- Resolute$160
- GENERAL VASCULAR ACCESS$124
- JARDIANCE$122
- XARELTO$121
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$119
How this compares
$13,253 in reported general payments places this provider in the 75th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 243 | $260,271 |
| XareltoRivaroxaban | 176 | $218,324 |
| EntrestoSacubitril/Valsartan | 154 | $185,345 |
| JardianceEmpagliflozin | 76 | $89,992 |
| Repatha SureclickEvolocumab | 82 | $69,888 |
| BrilintaTicagrelor | 32 | $17,095 |
| Metoprolol Succinate | 524 | $8,820 |
| Ezetimibe | 133 | $6,608 |
| Atorvastatin Calcium | 468 | $4,742 |
| Losartan Potassium | 305 | $3,311 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 91 | $3,254 |
| Rosuvastatin Calcium | 114 | $2,043 |
| Labetalol Hcl | 45 | $1,572 |
| Amlodipine Besylate | 236 | $1,485 |
| ClopidogrelClopidogrel Bisulfate | 91 | $1,291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $214 | $260,271243 claims |
| Johnson & JohnsonXarelto | $304 | $218,324176 claims |
| NovartisEntresto | $624 | $185,345154 claims |
| Boehringer IngelheimJardiance | $549 | $89,99276 claims |
| AstraZenecaBrilinta | $52 | $17,09532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 423 cardiovascular disease providers in Arizona.
Other cardiovascular disease in Bullhead City
- David RizikScottsdale$2.1M
- Rodrigo ChanMesa$2M
- Ashish GuptaPhoenix$1.2M
- Rajkumar SugumaranPhoenix$957K
- Krishnaswami VijayaraghavanScottsdale$927K
- Gregory KoshkarianTucson$608K
- Andrew KaplanMesa$455K
- Charles JostMesa$374K
- Steven MottlTucson$340K
- Steven LesterScottsdale$336K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.